Posts Tagged ‘Pere Ginés’

Thursday March 08th, 2018

A non-invasive method allows detecting a high frequency of undiagnosed chronic liver disease

Researchers at Hospital Clínic and IDIBAPS in collaboration with the USR Metropolitana Nord-IDIAP Jordi Gol, from the Catalan Institute of Health, have carried out a study to determine the frequency of chronic liver disease in the general population who show no signs of disease. They evaluated more than 3,000 people of whom about 4% had an undiagnosed advanced liver disease and at high risk of developing cirrhosis or liver cancer. The study was performed using the elastography, a non-invasive technique to measure liver fibrosis. Read the rest of this entry »

Comments Closed
Monday January 16th, 2017

Hospital Clinic-IDIBAPS leads a European project to fight against cirrhosis within the Horizon 2020 program

Hospital Clínic-IDIBAPS is leading a European project to evaluate the efficacy of treatment with the combination of rifaximin, an antibiotic that modulates the intestinal microbiome, and statins in patients with advanced cirrhosis. The project, called LIVERHOPE, will also focuse on the search for biomarkers of the disease. LIVERHOPE is coordinated by Dr. Pere Ginès, head of the Hepatology Department of the Hospital Clínic and of the team of Mechanisms of liver diseases and complications of cirrhosis of IDIBAPS, and a total of 16 institutions are participating among clinical centers, universities and European companies. This project is part of the Horizon 2020 European research and innovation framework program and it is endowed with a budget of 6 million euros.

Read the rest of this entry »

Comments Closed
Friday January 17th, 2014

Dr. Pere Ginès receives the German Lucie Bolte Prize

The Lucie Bolte Foundation annually awards the Lucie Bolte Prize, the most important German prize for research in hepatology. On January 24, Dr. Pere Ginès, head of the Hepatology Service of the Hospital Clínic and investigator at the IDIBAPS team Pathophysiology and treatment of ascites and altered renal function in liver cirrhosis and professor of Medicine at the University of Barcelona, will receive the award during the Congress of the German Society for the Study of the Liver to be held in Tübingen. The award recognizes an important and ongoing experience in the field of liver cirrhosis, and for the first time it will received by a Spanish researcher.

Comments Closed
Friday July 26th, 2013

CLIF Consortium describes a new syndrome in patients with acute decompensation of cirrhosis

Chronic liver failure is among the top ten causes of death in adults in many countries and constitutes the most common reason for hospital admission amongst all patients with liver diseases. The shortage of liver donors urges the scientific community to design effective treatments for chronic liver failure to improve quality of life and survival in these patients. The EASL-CLIF (European Association for the Study of the Liver – Chronic Liver Failure) consortium is a multicenter organization, coordinated from IDIBAPS – Hospital Clínic of Barcelona by the team led by Dr. Vicente Arroyo and Dr. Pere Ginés, specifically aimed at promoting research projects on Chronic Liver Failure. Recently this Consortium published an article in Gastroenterology, with Dr. Richard Moreau from Hôpital Beaujon (Paris, France) as its first author, describing acute-on-chronic liver failure as a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Read the rest of this entry »

Comments Closed